Célia Touraine
Célia Touraine
ICM (Montpellier Cancer Institute)
Verified email at icm.unicancer.fr
TitleCited byYear
Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
K Leffondré, C Touraine, C Helmer, P Joly
International journal of epidemiology 42 (4), 1177-1186, 2013
662013
Predictions in an illness-death model
C Touraine, C Helmer, P Joly
Statistical methods in medical research 25 (4), 1452-1470, 2016
422016
Gait speed and decline in gait speed as predictors of incident dementia
J Dumurgier, F Artaud, C Touraine, O Rouaud, B Tavernier, C Dufouil, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016
422016
The SmoothHazard package for R: Fitting regression models to interval-censored observations of illness-death models
C Touraine, TA Gerds, P Joly
Journal of Statistical Software 79 (7), 2017
26*2017
Prevalence projections of chronic diseases and impact of public health intervention
P Joly, C Touraine, A Georget, JF Dartigues, D Commenges, ...
Biometrics 69 (1), 109-117, 2013
182013
Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring
H Jacqmin-Gadda, P Blanche, E Chary, C Touraine, JF Dartigues
Statistical methods in medical research 25 (6), 2750-2766, 2016
72016
Modèles illness-death pour données censurées par intervalle: application à l'étude de la démence
C Touraine
Bordeaux 2, 2013
72013
SmoothHazard: Fitting illness-death model for interval-censored data
C Touraine, P Joly, TA Gerds
R package version 1 (3), 2014
52014
Distribution-and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
A Ousmen, C Touraine, N Deliu, F Cottone, F Bonnetain, F Efficace, ...
Health and quality of life outcomes 16 (1), 228, 2018
42018
ADL disability and death in dementia in a French population-based cohort: New insights with an illness-death model
F Delva, C Touraine, P Joly, A Edjolo, H Amieva, C Berr, O Rouaud, ...
Alzheimer's & Dementia 12 (8), 909-916, 2016
32016
More accurate cancer-related excess mortality through correcting background mortality for extra variables
C Touraine, N Grafféo, R Giorgi, CENSUR working survival group
Statistical methods in medical research, 0962280218823234, 2019
22019
Impact d’un programme d’activité physique et de conseil diététique sur la qualité de vie relative à la santé de femmes atteintes de cancer du sein non métastatique sous …
C Touraine, W Jacot, S Gourgou, M Carayol, G Ninot, P Senesse, ...
Revue d’Épidémiologie et de Santé Publique 66, S174, 2018
12018
Correcting for misclassification and selection effects in estimating net survival in clinical trials
JA Goungounga, C Touraine, N Grafféo, R Giorgi
BMC medical research methodology 19 (1), 104, 2019
2019
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review
E Charton, B Cuer, F Cottone, F Efficace, C Touraine, Z Hamidou, F Fiteni, ...
Quality of Life Research, 1-12, 2019
2019
Modélisation conjointe de la trajectoire de qualité de vie relative à la santé et du temps de «dropout» pour la prise en compte des données manquantes monotones potentiellement …
B Cuer, C Mollevi, T Conroy, B Juzyna, S Gourgou, C Touraine
Revue d'Épidémiologie et de Santé Publique 67, S144, 2019
2019
Analyse conjointe de la survie et de la qualité de vie relative à la santé chez des patients atteints de cancer du pancréas métastatique. Application aux données de l’essai …
C Touraine, B Cuer, T Conroy, B Juzyna, S Gourgou, C Mollevi
Revue d'Épidémiologie et de Santé Publique 67, S131, 2019
2019
Abstract P3-14-03: Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer
W Jacot, N Firmin, C Touraine, S Pouderoux, M Viala, M Metge, L Rifai, ...
Cancer Research 79 (4 Supplement), P3-14-03-P3-14-03, 2019
2019
Abstract P3-14-01: High-dose vitamin D supplementation for the correction of vitamin D insufficiency in patients undergoing adjuvant chemotherapy for breast cancer, a phase II …
W Jacot, V D'Hondt, C Touraine, A Chapelle, E Legouffe, M Metge, L Rifai, ...
Cancer Research 79 (4 Supplement), P3-14-01-P3-14-01, 2019
2019
High-dose vitamin D supplementation for the correction of vitamin D insufficiency in patients undergoing adjuvant chemotherapy for breast cancer, a phase II multicenter study
W Jacot, V D'Hondt, C Touraine, A Chapelle, E Legouffe, M Metge, L Rifai, ...
CANCER RESEARCH 79 (4), 2019
2019
Time to health-related quality of life score deterioration in oncology phase III clinical trials: a systematic review
E Charton, F Efficace, F Cottone, C Touraine, B Cuer, Z Hamidou, F Fiteni, ...
QUALITY OF LIFE RESEARCH 27, S34-S35, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20